Helen Quinn
- Microbiology top 0.2%
- Bacterial Infections and Vaccines 24
- Health top 0.5%
- Vaccine Coverage and Hesitancy 30
- Epidemiology top 1%
- Influenza Virus Research Studies 31
- Pneumonia and Respiratory Infections 18
- Respiratory viral infections research 14
- Virology and Viral Diseases 12
- Hepatitis B Virus Studies 7
- Parasitology top 2%
- Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology 7
- Co-authors
- Peter McIntyreKristine MacartneyJohn EllisNicholas WoodAlexis PillsburyPeter MasseyJulie LeaskGwendolyn L. Gilbert
- Cited by
- MicrobiologyHealthEpidemiology
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Helen Quinn
104 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 131
- Microbiology 958
- Health 849
- Epidemiology 1.8k
- Parasitology 302
- Infectious Diseases 658
Countries citing papers authored by Helen Quinn
This map shows the geographic impact of Helen Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Quinn more than expected).
Fields of papers citing papers by Helen Quinn
This network shows the impact of papers produced by Helen Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Quinn. The network helps show where Helen Quinn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Quinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 7 | |
| 4 | 2021 | 1 | |
| 5 | Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020 | 2020 | 5 |
| 6 | 2020 | 10 | |
| 7 | 2018 | 37 | |
| 8 | 2017 | 58 | |
| 9 | 2017 | 30 | |
| 10 | 2017 | 19 | |
| 11 | 2015 | 23 | |
| 12 | 2014 | 12 | |
| 13 | 2013 | 139 | |
| 14 | 2013 | 128 | |
| 15 | 2013 | 96 | |
| 16 | 2012 | 57 | |
| 17 | 2009 | 39 | |
| 18 | 2008 | 40 | |
| 19 | 2008 | 39 | |
| 20 | 2002 | 38 |
About Helen Quinn
Helen Quinn is a scholar working on Microbiology, Health and Epidemiology, having authored 106 papers that have together received 3.0k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (31 papers), Vaccine Coverage and Hesitancy (30 papers), Bacterial Infections and Vaccines (24 papers), Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (14 papers), Virology and Viral Diseases (12 papers), Hepatitis B Virus Studies (7 papers) and Viral gastroenteritis research and epidemiology (7 papers). The work is most often cited by research in Microbiology (958 citations), Health (849 citations) and Epidemiology (1.8k citations). Helen Quinn has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Peter McIntyre, Kristine Macartney, John Ellis, Nicholas Wood, Alexis Pillsbury, Peter Massey, Julie Leask, Gwendolyn L. Gilbert, Catherine Miller and Robert Menzies. Their work appears in journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.